Initiate the literature search to prioritise TAM targets for internal development and confirm the therapeutic value of anti-SIGLEC1 antibodies.

Project Details

StatusActive
Effective start/end date26/02/2025/02/22

Funding

  • UK industry, commerce and public corporations: £733,740.00